Regulus Therapeutics
RGLS
#9044
Rank
C$0.14 B
Marketcap
$2.19
Share price
10.51%
Change (1 day)
-33.01%
Change (1 year)

P/S ratio for Regulus Therapeutics (RGLS)

P/S ratio as of March 2025 (TTM): N/A

According to Regulus Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.16. At the end of 2024 the company had a P/S ratio of N/A.

P/S ratio history for Regulus Therapeutics from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
2024N/A
2023N/A
2022N/A
2021N/A-100%
20208.57212.92%
20192.74-97.6%
2018114-92.41%
2017> 10001405.64%
201699.7350.77%
201522.1-78.39%
2014102548.71%
201315.8-11.22%
201217.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.99N/A๐Ÿ‡ฌ๐Ÿ‡ง UK
3.02N/A๐Ÿ‡ซ๐Ÿ‡ท France
2.11N/A๐Ÿ‡บ๐Ÿ‡ธ USA
4.44N/A๐Ÿ‡ฌ๐Ÿ‡ง UK
13.9N/A๐Ÿ‡บ๐Ÿ‡ธ USA
3.95N/A๐Ÿ‡บ๐Ÿ‡ธ USA
2.47N/A๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA